Pantodac

Product Description

Pantodac is a pharmaceutical preparation containing Pantoprazole as its active component. This medication falls under the class of proton pump inhibitors (PPIs) and is primarily indicated for managing disorders associated with excessive gastric acid secretion.

Indications

Pantodac is clinically prescribed for the treatment of:

• Gastroesophageal reflux disease (GERD): Effectively reduces gastric acid production, alleviating symptoms including heartburn, acid regurgitation, and reflux.
• Peptic ulcer disease: Facilitates healing and prevents recurrence of gastric and duodenal ulcers.
• Zollinger-Ellison syndrome: Controls pathological hypersecretion of gastric acid characteristic of this rare disorder.

Administration Guidelines

The recommended administration of Pantodac involves oral intake, typically once daily prior to a meal. Tablets should be swallowed intact with water, without chewing or crushing. Treatment duration varies according to the specific clinical indication and should be determined by a healthcare provider.

Mechanism of Action

Pantodac exerts its therapeutic effect through selective inhibition of the hydrogen-potassium ATPase enzyme system (proton pump) in gastric parietal cells. This action suppresses basal and stimulated acid secretion, thereby reducing gastric acidity and promoting mucosal healing.

Therapeutic Advantages

The principal clinical benefits of Pantodac include:

• Effective acid suppression: Provides symptomatic relief from acid-related disorders including pyrosis and regurgitation.
• Ulcer management: Enhances healing of existing ulcers and reduces ulcer recurrence rates.
• Control of pathological hypersecretion: Manages the excessive acid production associated with Zollinger-Ellison syndrome.

Adverse Effects

The following adverse reactions may occur during Pantodac therapy:

• Cephalalgia (headache)
• Diarrhea
• Nausea
• Abdominal discomfort
• Flatulence

These effects are typically transient and mild in nature. Persistent or severe symptoms warrant medical consultation.

Dosage Protocol

Dosage regimens are individualized based on clinical indication and patient characteristics. Standard dosing involves oral administration of one 40 mg tablet daily before breakfast. Treatment duration should be determined by a qualified medical practitioner.

Precautions

Important safety considerations include:

• Hypersensitivity: Contraindicated in patients with known hypersensitivity to pantoprazole or other PPIs.
• Drug interactions: Potential interactions with digoxin, warfarin, and certain azole antifungals necessitate comprehensive medication review.
• Special populations: Medical supervision required for pregnant, lactating, or childbearing-age women.
• Long-term therapy: Extended PPI use may be associated with increased risk of infections, osteoporotic fractures, and cobalamin deficiency, requiring periodic monitoring.

Storage Conditions

Maintain Pantodac tablets in their original packaging at controlled room temperature (15-30°C), protected from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date indicated on packaging. Dispose of expired or unused medication according to pharmaceutical waste guidelines.